Sale is live|00:00:00
Excel Industries LtdQ1 FY26

Excel Industries Ltd

Q1 FY26 Earnings Call Analysis

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Excel Industries aims for growth by focusing on Performance Solutions, contract manufacturing, and YP derivatives as key growth drivers.
  • Export share is expected to increase, especially by expanding presence in the EU and potentially the US markets.
  • Contract manufacturing is seen as a growing segment, with more international multinational customer deals expected.
  • The company plans to launch new products, particularly in the biocides segment, to drive revenue.
  • Capacity utilization currently ranges from 65% to 85%, with planned capacity additions targeting focus areas.
  • Organic capex of INR200-300 crores planned over 2-3 years, with expected ROI of 15-20% and fixed asset turnover of 1 to 1.5 times.
  • Management remains committed to delivering sustainable long-term value amid business cyclicity and market uncertainties.

Margin guidance

Category 3
  • Excel Industries aims for growth through capex deployment in key areas: Performance Solutions, contract manufacturing, and YP derivatives.
  • Fixed asset turnover from planned capex is expected at 1 to 1.5 times with an ROI of 15%-20%.
  • The company acknowledges business cyclicity; growth is expected when operational and market conditions normalize.
  • Contract manufacturing and exports are key growth drivers and their contribution is expected to increase over time.
  • Biocides segment within Performance Solutions is targeted for fastest growth.
  • New product launches, including a biocide product in H2 FY27, will enhance revenues.
  • Management refrains from giving exact growth rates but aims to improve earnings by strategic investments and long-term value creation.
  • EBITDA growth and PAT improvement are expected gradually, reflecting capacity additions and market expansion.
  • The company continues to focus on maintaining or increasing market share through dynamic pricing strategies.

Sign up free to read the full earnings analysis

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Excel Industries Ltd and 1,400+ other companies.

Fundraise plans

  • There is no mention of any current or planned fundraising through debt or equity in the provided transcript.
  • The company stated it has a strong balance sheet with zero long-term debt and a net cash positive position.
  • Capex plans are focused on organic investments in growth areas like Performance Solutions, contract manufacturing, and YP derivatives, funded internally.
  • No specific announcements or intentions regarding raising capital via debt or equity were disclosed during the Q4 and FY26 earnings call.

Order book

  • No specific details on the current or expected order book or pending orders were disclosed in the call transcript.
  • Ravi Shroff mentioned ongoing contract manufacturing agreements progressing well, with validation batches dispatched and capacity expected to come on stream by July 2026.
  • The contract manufacturing segment has a funnel of customer qualifications in trial or audit stages, though exact numbers and conversion rates are not specified.
  • New product launches (e.g., biocides) in Performance Solutions segment are planned, indicating a pipeline of growth opportunities.
  • The company is actively pursuing growth through exports, contract manufacturing, and Performance Solutions, suggesting a positive outlook on order inflow.
  • Exact order book size or pending orders data were not shared due to commercial confidentiality and the early stage of some projects.

Capex plans

Yes
  • Excel Industries plans capex of around INR 200-300 crores over the next 2-3 years, targeting key growth areas.
  • Focus areas for capex include Performance Solutions, contract manufacturing, and YP derivatives.
  • Fixed asset turnover expected to be 1 to 1.5 times, with an expected ROI of 15%-20%.
  • Capex deployment details will be disclosed as and when significant investments occur.
  • Company remains open to inorganic capex where strategic opportunities provide technology or market access.
  • Additional capacity is maintained to manage cyclicity and supply chain disruptions, ensuring customer servicing and opportunity capture.
  • Expansion efforts include potential increasing market presence in EU and the US, especially in Performance Solutions.
  • No specific timelines or further details on new projects shared yet; disclosures will be made when appropriate.

How does Excel Industries Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature
1Excel Industries Ltd
Rev 3Mar 3

See full Chemicals & Petrochemicals sector rankings

Unlock with Pro

Want more stocks like Excel Industries Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio